Dr. Reddy`s Laboratories Ltd
Research Dr. Reddy`s Laboratories Ltd (RDY) on Bullrun: market cap USD 10.15B, P/E 27.4, dividend yield 0.7%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerRDY
- ExchangeNYSE
- CountryIndia
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Market capUSD 10.15B
- P/E27.4
- Dividend yield0.7%
- Financial periodQ2 2026
- RevenueINR 80.71B
- Net incomeINR 4.44B
- Free cash flow-INR 4.63B
- Gross margin46.5%
Valuation Snapshot
latest market cap is USD 10.15B; P/E is 27.4; dividend yield is 0.7%.
Peer valuation comparison
Latest P/E is 27.37x versus a Healthcare sector median of 24.34x (12.5% above).
Latest dividend yield is 0.68% versus a Healthcare sector median of 2.12% (67.9% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | INR 345.83B | INR 56.59B | INR 24.26B | 55.2% | 67.89 | INR 18.66B | INR 67.73B | INR 372.37B |
| FY2024 | INR 311.31B | INR 53.68B | INR 6.52B | 59.3% | 64.39 | INR 12.29B | INR 51.09B | INR 317.72B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-28 | USD 10.15B | 27.4 | 0.7% | 0.08 |
| 2025 | 2025-12-31 | USD 11.69B | 18.0 | 0.6% | 0.09 |
| 2024 | 2024-12-31 | USD 13.15B | 20.5 | 0.6% | 0.1 |
| 2023 | 2023-12-29 | USD 11.59B | 18.8 | 1.4% | 0.2 |
| 2022 | 2022-12-30 | USD 8.59B | 21.6 | 4.5% | 0.47 |
| 2021 | 2021-12-31 | USD 10.88B | 30.4 | 0.5% | 0.07 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.08 USD, yield 0.7%.
About Dr. Reddy`s Laboratories Ltd
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. The company operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Dr. Reddy`s Laboratories Ltd's market cap?
Dr. Reddy`s Laboratories Ltd's market capitalization is USD 10.15B.
What is Dr. Reddy`s Laboratories Ltd's P/E ratio?
Dr. Reddy`s Laboratories Ltd's price-to-earnings (P/E) ratio is 27.4.
Does Dr. Reddy`s Laboratories Ltd pay a dividend?
Dr. Reddy`s Laboratories Ltd has a dividend yield of 0.7%.
What does Dr. Reddy`s Laboratories Ltd do?
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. The company operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. Its Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business.